Source:http://linkedlifedata.com/resource/pubmed/id/17320759
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2007-2-26
|
pubmed:abstractText |
Control of the transcription factor hypoxia inducible factor (HIF)-1 is mediated by hydroxylation by proline and asparagine hydroxylases. These enzymes require ascorbate for optimal activity, but little attention has been given to the effect of ascorbate on HIF-1 activation. Furthermore, cells in culture are ascorbate deficient. We investigated the effect of intracellular ascorbate on HIF-1alpha protein levels and on HIF-1-mediated gene expression in two human primary cell lines (umbilical vein endothelial cells and skin fibroblasts) and one human cancer cell line (A431 epithelial cells). Under normal culture conditions the cells contained no ascorbate and adding ascorbate to the medium increased intracellular concentrations in a dose-dependent manner. A basal level of HIF-1alpha detected in nonsupplemented cells under normoxic conditions disappeared when 10 microM ascorbate was added to the medium. Induction of HIF-1alpha by hypoxia (1% O(2)) or by CoCl(2) was markedly inhibited by ascorbate and loading with physiological levels resulted in almost complete reversal of HIF-1alpha stabilisation. Gene expression was similarly affected, with VEGF mRNA and GLUT-1 up-regulation being inhibited by ascorbate. Hence intracellular ascorbate is a major regulator of the hypoxic response in normal cells and optimal levels of this vitamin will have a profound effect on HIF-1-regulated processes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Ascorbic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose Transporter Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxia-Inducible Factor 1, alpha...,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0891-5849
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
765-72
|
pubmed:meshHeading |
pubmed-meshheading:17320759-Anoxia,
pubmed-meshheading:17320759-Ascorbic Acid,
pubmed-meshheading:17320759-Blotting, Western,
pubmed-meshheading:17320759-Cell Line, Tumor,
pubmed-meshheading:17320759-Cells, Cultured,
pubmed-meshheading:17320759-Dose-Response Relationship, Drug,
pubmed-meshheading:17320759-Endothelium, Vascular,
pubmed-meshheading:17320759-Fibroblasts,
pubmed-meshheading:17320759-Gene Expression Regulation,
pubmed-meshheading:17320759-Glucose Transporter Type 1,
pubmed-meshheading:17320759-Humans,
pubmed-meshheading:17320759-Hypoxia-Inducible Factor 1, alpha Subunit,
pubmed-meshheading:17320759-RNA, Messenger,
pubmed-meshheading:17320759-Vascular Endothelial Growth Factor A
|
pubmed:year |
2007
|
pubmed:articleTitle |
Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate.
|
pubmed:affiliation |
Free Radical Research Group, Pathology Department, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand. margret.vissers@chmeds.ac.nz
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|